| TSORX | VDVIX | TSORX / VDVIX | |
| Total Expense Ratio | 0.58 | 0.16 | 362% |
| Annual Report Gross Expense Ratio | 0.71 | 0.16 | 444% |
| Fund Existence | 11 years | 13 years | - |
| Gain YTD | 10.678 | 16.464 | 65% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2500 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.85B | 315B | 1% |
| Annual Yield % from dividends | 3.58 | 2.37 | 151% |
| Returns for 1 year | 17.00 | 25.29 | 67% |
| Returns for 3 years | 54.41 | 61.54 | 88% |
| Returns for 5 years | 39.11 | 39.41 | 99% |
| Returns for 10 years | 109.84 | 103.65 | 106% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LABD | 6.39 | 0.11 | +1.75% |
| Direxion Daily S&P Biotech Bear 3X ETF | |||
| FTGS | 38.90 | 0.37 | +0.95% |
| First Trust Growth Strength ETF | |||
| FLRG | 42.77 | 0.38 | +0.90% |
| Fidelity U.S. Multifactor ETF | |||
| RSMR | 24.28 | 0.05 | +0.21% |
| FT Vest U.S. Equity Equal Weight Buffer ETF - March | |||
| RTAI | 20.48 | -0.06 | -0.30% |
| Rareview Tax Advantaged Income ETF | |||